Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Level of Agreement With a Multi-Test Approach to the Diagnosis of Diabetic Foot Osteomyelitis.

Meyr AJ, Seo K, Khurana JS, Choksi R, Chakraborty B.

J Foot Ankle Surg. 2018 Nov - Dec;57(6):1137-1139. doi: 10.1053/j.jfas.2018.05.010. Epub 2018 Sep 1.

PMID:
30181032
2.

Activation of Focal Adhesion Kinase and Src Mediates Acquired Sorafenib Resistance in A549 Human Lung Adenocarcinoma Xenografts.

Zhou Q, Guo X, Choksi R.

J Pharmacol Exp Ther. 2017 Dec;363(3):428-443. doi: 10.1124/jpet.117.240507. Epub 2017 Oct 11.

PMID:
29021381
3.

Sarcopenia, age, atrophy, and myopathy: Mitochondrial oxidative enzyme activities.

Pestronk A, Keeling R, Choksi R.

Muscle Nerve. 2017 Jul;56(1):122-128. doi: 10.1002/mus.25442. Epub 2017 Feb 8.

PMID:
27759889
4.

Flexural properties and impact strength of denture base resins reinforced with micronized glass flakes.

Choksi RH, Mody PV.

J Indian Prosthodont Soc. 2016 Jul-Sep;16(3):264-70. doi: 10.4103/0972-4052.176532.

5.

Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology.

Alshehri A, Choksi R, Bucelli R, Pestronk A.

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 4;2(4):e124. doi: 10.1212/NXI.0000000000000124. eCollection 2015 Aug.

6.

Myelinated and unmyelinated endoneurial axon quantitation and clinical correlation.

Dori A, Lopate G, Choksi R, Pestronk A.

Muscle Nerve. 2016 Feb;53(2):198-204. doi: 10.1002/mus.24740. Epub 2015 Aug 8.

PMID:
26080797
7.

A Regularization Approach to Blind Deblurring and Denoising of QR Barcodes.

van Gennip Y, Athavale P, Gilles J, Choksi R.

IEEE Trans Image Process. 2015 Sep;24(9):2864-73.

PMID:
25974935
8.

Tofogliflozin: a highly selective SGLT2 inhibitor for the treatment of type 2 diabetes.

Rosenwasser RF, Rosenwasser JN, Sutton D, Choksi R, Epstein B.

Drugs Today (Barc). 2014 Nov;50(11):739-45. doi: 10.1358/dot.2014.50.11.2232267. Review.

PMID:
25525634
9.

Regional ischemic immune myopathy: a paraneoplastic dermatomyopathy.

Cai C, Alshehri A, Choksi R, Pestronk A.

J Neuropathol Exp Neurol. 2014 Dec;73(12):1126-33. doi: 10.1097/NEN.0000000000000132.

PMID:
25383636
10.

SGLT-2 inhibitors and their potential in the treatment of diabetes.

Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ.

Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. Review.

11.

Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS.

Pestronk A, Schmidt RE, Choksi RM, Sommerville RB, Al-Lozi MT.

Muscle Nerve. 2012 Jun;45(6):866-72. doi: 10.1002/mus.23256.

PMID:
22581541
12.

Dapagliflozin: a novel sodium-glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.

Shah NK, Deeb WE, Choksi R, Epstein BJ.

Pharmacotherapy. 2012 Jan;32(1):80-94. doi: 10.1002/PHAR.1010. Review.

PMID:
22392830
13.

Less RAAS is more, or not.

Shah NK, Choksi R, Epstein BJ.

Expert Rev Cardiovasc Ther. 2011 Nov;9(11):1363-5. doi: 10.1586/erc.11.136. No abstract available.

PMID:
22059783
14.

Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside.

Pestronk A, Chuquilin M, Choksi R.

J Neurol Neurosurg Psychiatry. 2010 Jul;81(7):726-30. doi: 10.1136/jnnp.2009.202796.

PMID:
20581137
15.

Vascular pathology in dermatomyositis and anatomic relations to myopathology.

Pestronk A, Schmidt RE, Choksi R.

Muscle Nerve. 2010 Jul;42(1):53-61. doi: 10.1002/mus.21651.

PMID:
20544925
16.

Recent changes in the landscape of combination RAS blockade.

Epstein BJ, Smith SM, Choksi R.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Review.

PMID:
19900020
17.

Osteoclasts are important for bone angiogenesis.

Cackowski FC, Anderson JL, Patrene KD, Choksi RJ, Shapiro SD, Windle JJ, Blair HC, Roodman GD.

Blood. 2010 Jan 7;115(1):140-9. doi: 10.1182/blood-2009-08-237628. Epub 2009 Nov 3.

18.

Improving the damage accumulation in a biomechanical bone remodelling model.

Restrepo JM, Choksi R, Hyman JM, Jiang Y.

Comput Methods Biomech Biomed Engin. 2009 Jun;12(3):341-52. doi: 10.1080/10255840802609404.

PMID:
19089785
19.

A mammalian microRNA expression atlas based on small RNA library sequencing.

Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foà R, Schliwka J, Fuchs U, Novosel A, Müller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T.

Cell. 2007 Jun 29;129(7):1401-14.

20.

Peripheral neuropathies in Waldenström's macroglobulinaemia.

Levine T, Pestronk A, Florence J, Al-Lozi MT, Lopate G, Miller T, Ramneantu I, Waheed W, Stambuk M, Stone MJ, Choksi R.

J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):224-8.

21.

Ring-enhancing lesion in central pontine myelinolysis.

Choksi R, Roach ES.

Arch Neurol. 2005 Jun;62(6):1016-7. No abstract available.

PMID:
15956178
22.

Otitic hydrocephalus revisited.

Bari L, Choksi R, Roach ES.

Arch Neurol. 2005 May;62(5):824-5. No abstract available.

PMID:
15883272
23.

Treatment of IgM antibody associated polyneuropathies using rituximab.

Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi MT, Levine TD.

J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):485-9.

24.

Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide.

Pestronk A, Choksi R, Logigian E, Al-Lozi MT.

Muscle Nerve. 2003 Feb;27(2):188-95.

PMID:
12548526
25.

Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.

Lopate G, Choksi R, Pestronk A.

Muscle Nerve. 2002 Jun;25(6):828-36.

PMID:
12115971
26.

Anti-myelin associated glycoprotein antibodies: variability in patterns of IgM binding to peripheral nerve.

Lopate G, Kornberg AJ, Yue J, Choksi R, Pestronk A.

J Neurol Sci. 2001 Jul 15;188(1-2):67-72.

PMID:
11489287
27.

Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies.

Pestronk A, Choksi R, Yee WC, Kornberg AJ, Lopate G, Trotter J.

J Neuroimmunol. 1998 Nov 2;91(1-2):204-9.

PMID:
9846837
28.
30.

IgM anti-sulfatide autoantibodies: patterns of binding to cerebellum, dorsal root ganglion and peripheral nerve.

Lopate G, Pestronk A, Kornberg AJ, Yue J, Choksi R.

J Neurol Sci. 1997 Oct 22;151(2):189-93.

PMID:
9349675
31.

Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.

Pestronk A, Choksi R, Blume G, Lopate G.

Neurology. 1997 Apr;48(4):1104-6.

PMID:
9109910
32.

Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.

Connolly AM, Pestronk A, Planer GJ, Yue J, Mehta S, Choksi R.

Neurology. 1996 Mar;46(3):810-14.

PMID:
8618688
33.

Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein.

Pestronk A, Choksi R, Bieser K, Goldstein JM, Adler CH, Caselli RJ, George EB.

Muscle Nerve. 1994 Nov;17(11):1293-300.

PMID:
7523945
34.

Nerve-dependent recovery of metabolic pathways in regenerating soleus muscles.

Sesodia S, Choksi RM, Nemeth PM.

J Muscle Res Cell Motil. 1994 Oct;15(5):573-81.

PMID:
7860705
35.

Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation.

Pestronk A, Li F, Bieser K, Choksi R, Whitton A, Kornberg AJ, Goldstein JM, Yee WC.

Neurology. 1994 Jun;44(6):1131-7.

PMID:
7516055
36.

Whole-body energy metabolism and skeletal muscle biochemical characteristics.

Zurlo F, Nemeth PM, Choksi RM, Sesodia S, Ravussin E.

Metabolism. 1994 Apr;43(4):481-6.

PMID:
8159108
37.

Effects of microgravity and tail suspension on enzymes of individual soleus and tibialis anterior fibers.

Chi MM, Choksi R, Nemeth P, Krasnov I, Ilyina-Kakueva E, Manchester JK, Lowry OH.

J Appl Physiol (1985). 1992 Aug;73(2 Suppl):66S-73S.

PMID:
1388150
38.

Metabolic transitions in rat jaw muscles during postnatal development.

Hurov J, Rosser BW, Baker KM, Choksi R, Norris BJ, Nemeth PM.

J Craniofac Genet Dev Biol. 1992 Apr-Jun;12(2):98-106.

PMID:
1613079
39.

Metabolic response to a high-fat diet in neonatal and adult rat muscle.

Nemeth PM, Rosser BW, Choksi RM, Norris BJ, Baker KM.

Am J Physiol. 1992 Feb;262(2 Pt 1):C282-6.

PMID:
1539619
40.

IMP response: an indicator of metabolic stress in working muscle.

Heller SL, Choksi R, Brooke MH.

Muscle Nerve. 1986 Jul-Aug;9(6):515-8.

PMID:
3736584
41.

Inosine monophosphate production is proportional to muscle force in vitro.

Brooke MH, Choksi R, Kaiser KK.

Neurology. 1986 Feb;36(2):288-91.

PMID:
3945403
42.

Skeletal muscle fatty acid oxidation during early postnatal development in the rat.

Carroll JE, Shumate JB, Villadiego A, Choksi RM, Morse DP.

Biol Neonate. 1983;43(3-4):191-7.

PMID:
6222770
43.

Incomplete palmitate oxidation. Possible source of human myopathy.

Shumate JB, Brooke MH, Carroll JE, Choksi RM.

Arch Neurol. 1982 Sep;39(9):561-4.

PMID:
7115144
44.

Palmitate oxidation in human muscle: comparison to CPT and carnitine.

Shumate JB, Carroll JE, Brooke MH, Choksi RM.

Muscle Nerve. 1982 Mar;5(3):226-31.

PMID:
7088021
45.

Cyanide insensitive palmitate oxidation in skeletal muscle.

Shumate JB, Choksi RM.

Biochem Biophys Res Commun. 1981 Jun 16;100(3):978-81. No abstract available.

PMID:
7271814
46.

Evaluation of a program for weight control for obese children and adolescents.

Choksi R, Bower PB, Pollard V, Mankad VN.

IMJ Ill Med J. 1980 Apr;157(4):232-5. No abstract available.

PMID:
6102975
47.

Letter: The fetal alcohol syndrome.

Mankad VN, Choksi RM.

JAMA. 1976 Sep 6;236(10):1114. No abstract available.

PMID:
988860

Supplemental Content

Loading ...
Support Center